Latest News about ALDX
Recent news which mentions ALDX
70 Biggest Movers From Friday
May 02, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 29, 2022
From Benzinga
48 Stocks Moving In Friday's Mid-Day Session
April 29, 2022
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 29, 2022
From Benzinga
From Benzinga
From Benzinga
Aldeyra Therapeutics (ALDX) Q4 2021 Earnings Call Transcript
March 18, 2022
Tickers
ALDX
From Motley Fool
From Benzinga
Earnings Scheduled For March 17, 2022
March 17, 2022
From Benzinga
From Benzinga
Aldeyra Therapeutics Announces Publication Of Phase 2 Clinical Trial Of Reproxalap In Allergen Chamber Model
February 01, 2022
Tickers
ALDX
From Benzinga
55 Biggest Movers From Yesterday
December 22, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Jumps Over 500 Points; Rite Aid Shares Spike Higher
December 21, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 21, 2021
From Benzinga
From Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
December 21, 2021
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 21, 2021
From Benzinga
From InvestorPlace
10 Biggest Price Target Changes For Tuesday
December 21, 2021
From Benzinga
26 Stocks Moving in Tuesday's Pre-Market Session
December 21, 2021
From Benzinga
Aldeyra's Dry Eye Disease Candidate Disappoints In Late-Stage Study
December 21, 2021
Tickers
ALDX
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 02, 2021
From Benzinga
Aldeyra's Dry Eye Disease Trial Meets Primary Endpoint, But Did Not Reach Statistical Significance
November 02, 2021
Tickers
ALDX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.